23 Jul, 2026
According to Straits Research, the global medical aesthetic devices market, valued at $29.05 billion in 2025, is projected to grow from $32.29 billion in 2026 to $77.31 billion by 2034 at a CAGR of 11.53% during the forecast period 2026–2034.
Medical aesthetics is used to treat and enhance the aesthetic appearance of a person by treating conditions such as skin laxity, cellulite, scars, moles, wrinkles, unwanted hair, excessive fat, liver spots, spider veins, and skin discoloration. It includes dermatology, oral and maxillofacial, plastic, and reconstructive surgery. Medical aesthetics is extensively utilized in hospitals, clinics, medical spas, and beauty centers worldwide because it is quick, safe, effective, minimally invasive, requires little downtime, reduces the signs of aging, enhances the natural appearance, and has a lasting effect.
Obesity has increased significantly worldwide, particularly in the last few decades. Lifestyle disorders are found to affect the rising prevalence of obesity significantly. Increased alcohol consumption, a lack of physical activity, and poor eating habits are the primary causes of the growing obesity epidemic.
In June 2021, the World Health Organization reported that 39 million children under five were overweight or obese in 2020, an increase from 38.2 million in 2019. This population-wide increase in obesity is anticipated to increase demand for aesthetic devices for body reshaping, body contouring, and cellulite reduction, among other procedures. Thus, it is anticipated to drive the market expansion for medical aesthetic devices over the forecast period.
Medical aesthetics technology advancements and growing target population demand are expected to fuel the expansion of the global market for medical aesthetic devices. For instance, in March 2022, aesthetic device manufacturer Lumenis introduced the Splendor X device to the UK market. The new device has been granted CE clearance for hair removal, pigmented lesions, vascular treatments, and wrinkle treatment.
Likewise, in April 2022, BTL introduced industry-leading aesthetic devices to the UK beauty industry, including Emsculpt, Emtone, and Exilis Ultra360. Emsculpt employs patented HIFEM technology to generate an electromagnetic field that targets muscle groups, such as the abdomen, buttocks, arms, and legs, and induces supramaximal contractions that the body cannot naturally perform; 20,000 contractions in a 30-minute treatment to build muscle and reduce fat.
North America held a dominant position in the market in 2025 with a share of 44.27%. The market is growing due to the strong presence of advanced healthcare infrastructure, high consumer spending on cosmetic procedures, and strict regulatory frameworks supporting safe device adoption. In the US, aesthetic devices such as dermal fillers, lasers, and skin resurfacing technologies are regulated and approved by the US Food and Drug Administration (FDA), which evaluates clinical data to ensure safety and effectiveness before commercialization. This regulatory oversight encourages the adoption of technologically advanced devices in dermatology clinics and medical spas. The region also performs a high volume of aesthetic procedures.
The Asia Pacific market is anticipated to register a CAGR of 13.53% during the forecast period. The market is growing due to increasing demand for cosmetic procedures and rising healthcare investments across emerging economies. Countries such as South Korea, Japan, China, and India have become major hubs for aesthetic procedures and cosmetic dermatology services. According to global aesthetic surgery statistics, the total number of surgical and non-surgical cosmetic procedures worldwide exceeded 34.9 million, with several Asian countries contributing significantly to this growth due to the expanding middle-class population and increasing acceptance of minimally invasive treatments. The region also benefits from the expansion of medical tourism, particularly in South Korea and Thailand, where international patients seek aesthetic treatments using advanced medical devices.
sales@straitsresearch.com